510(k) Report

510(k) · Cleared

Recalled · Class II · 2023

AM Usa 0.9% Sodium Chloride Flush Syringe

K113555510(k) SpecialCleared Jan 30, 201260-day reviewClass II21 CFR 880.5200Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Am USA · NGT Saline, Vascular Access Flush

Cleared on Jan 30, 2012 as substantially equivalent to K111034 (Am USA, 2011) after a 60-day review. Its family tree reaches back 2 generations to 1999. It has been recalled once.

Decided
Jan 30, 2012
Review
60 days
Class
Class II
Product code
NGT
Recalls
1
Predicates
1

Its longest line of descent runs back 2 generations to K984590 (1999). No later device cites it as a predicate yet.

  1. Root · 2 generations backK984590 0.9% Sodium Chloride Flush SyringeBaxter Healthcare Corp · 1999 · Recalled
  2. 1 generation backK111034 AM Usa 0.9% Sodium Chloride Flush SyringeAm USA · 2011 · Recalled
  3. This deviceK113555 AM Usa 0.9% Sodium Chloride Flush SyringeAm USA · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K9845900.9% Sodium Chloride Flush SyringeBaxter Healthcare Corp19991
−1K111034AM Usa 0.9% Sodium Chloride Flush SyringeAm USA20112
0 (this device)K113555AM Usa 0.9% Sodium Chloride Flush SyringeAm USA2012—
FIG. 1 — Lineage of K113555, 1999–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NGT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NGT device

  1. #1 K250884 0.9 % Sodium Chloride Injection, USP, BD…score 11.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K111034AM Usa 0.9% Sodium Chloride Flush SyringeAm USA20112

Also cleared against K111034: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 28, 2023Class IIZ-1174-2024Under Investigation by firmThe saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 2 companies; a new generation was cleared every 11.8 years on median.
  • 2 of the 2 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K111034.

How does its category compare?

All NGT devices

NGT Saline, Vascular Access Flush: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · NGT

1in 2025

2008: 12009: 12010: 22011: 32012: 42013: 12014: 32015: 12016: 12017: 22018: 12019: 22020: 22022: 32023: 62024: 12025: 1
2007high 6 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NGT

142in 2023

2011: 219 days median2012: 106 days median2014: 87 days median2022: 151 days median2023: 142 days median
2007high 219 (2011) · low 87 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NGT

1in 2025

2007: 22009: 12010: 72011: 12012: 12013: 1, 1 Class I2016: 1, 1 Class I2019: 22021: 1, 1 Class I2022: 12023: 3, 2 Class I2025: 12026 (partial year): 1, 1 Class I
2007high 7 (2010) · low 0 (2008)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · NGT

212in 2025

2007: 312008: 642009: 182010: 232011: 202012: 52013: 252014: 252015: 142016: 822017: 562018: 2702019: 3402020: 3222021: 5662022: 2822023: 3132024: 3322025: 212
2007high 566 (2021) · low 5 (2012)2025

MAUDE reports naming product code NGT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—231
20081—064
20091—118
20102—723
20113219120
2012410615
20131—1 (1)25
2014387025
20151—014
20161—1 (1)82
20172—056
20181—0270
20192—2340
20202—0322
20210—1 (1)566
202231511282
202361423 (2)313
20241—0332
20251—1212
20260—1 (1)—

What is it indicated for?

0.9% Sodium Chloride Flush Syringes are intended for use in flushing compatible intravenous administration sets and indwelling intravenous access devices. Use according to the recommendations of the manufacture for the appropriate device.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K113555: AM Usa 0.9% Sodium Chloride Flush Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K113555

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026